Jorge A Salazar Melendez

Jorge A Salazar Melendez possesses extensive experience in the pharmaceutical and medical device industries, currently serving as Ad Interim Global Regulatory Strategy and Chief Scientific Officer at Welwaze Medical, Inc. since January 2019. In previous roles, Melendez held the position of Medical Director within the pharmaceutical industry across various regions, including Latin America, Europe, and the USA, from January to December 2018, and has substantial expertise in therapeutic areas such as hypertension, diabetes, and breast cancer. Melendez's career at Novartis spanned from 2004 to 2018, during which key roles included Regional Medical Director for Cardio-Metabolic and Critical Care Franchises, leading medical strategy and team development across Latin America and Canada. Academic qualifications include degrees in Cardiology and Internal Medicine, with specialization in Clinical Hypertension.